Premarket Movers Oct 16, 2026: Why ZTG, TCRT, NCPL Are Up
Why is ZTG up? Premarket movers today: ZTG, TCRT, NCPL and XLAB are surging before the open on an AI deal MOU, biotech financing and more.
ZTG — Zenta Group Co Ltd (+56.2%)
Why is ZTG up? Zenta Group is the biggest premarket mover, up 56.2% to $0.96 on 80,714,191 shares. That is far above its 20-day average volume of about 4.1 million, though premarket volume is lighter than regular hours. The company's market cap is only about $7.1 million.
The catalyst: Zenta's subsidiary ZentoAI signed a binding memorandum of understanding (MOU) to acquire a controlling stake in a privately held, profitable mainland China AI and big-data provider, per a GlobeNewswire release dated October 16, 2026. Payment may be cash and/or newly issued equity. The MOU does not obligate either side to finish the deal, and due diligence, definitive agreements and board approvals are still pending. It follows an October 13 announcement that the company was refocusing on AI and data solutions (StockTitan). Benzinga earlier reported ZTG up 40.7% to $0.88 in premarket.
The prior-day setup was weak. ZTG carried no pattern signal into the session, with RSI at 35, ADX at 15 (a weak trend), a gap of -7.0% and a price 94.1% below its 52-week high. Its conviction score is 0/100 (grade D). The squeeze score is 11/100, with 23.0% free float (the shares available to trade), 0.2 days to cover and 36% short-volume.
This is a sub-$1, micro-cap stock moving on a non-binding-to-close deal. Moves like this often reverse.
TCRT — Alaunos Therapeutics, Inc. (+31.0%)
Alaunos is up 31.0% to $2.81 on 12,150,855 premarket shares, against a 20-day average of about 18.4 million. Market cap is about $5.4M.
The backdrop is deal news from earlier this week. On October 13, Alaunos announced it completed its acquisition of Velaris Therapeutics, a private pulmonary arterial hypertension developer. The same release described a roughly $350 million private placement, reported as oversubscribed and led by Fairmount. StocksToTrade tied Friday's move to those headlines. The money came via Series C non-voting convertible preferred stock, which traders should watch for future dilution. No new October 16 event has been identified.
Recent filings add to the picture: an activist Schedule 13D and a 13D/A on October 15 (one bullish, one neutral), plus bearish-tagged 8-Ks on dilution (Oct. 13) and delisting (Oct. 9). Stock Titan reported two 9.99% holders agreed to back merger votes in a conditional repurchase deal. TCRT also featured in our after-hours recap for Oct. 15.
Technically, the prior-day chart showed a bullish harami candle, RSI 61, ADX 57, a mixed moving-average stack and a price 50.8% below its 52-week high. RS rating is 20, conviction 37/100 (grade D). The squeeze score is 15/100 with 77.7% free float, 0.3 days to cover and an active short-sale restriction (SSR), which limits short selling after a big drop.
NCPL — Netcapital Inc. (+30.4%)
Netcapital is up 30.4% to $2.55 on 10,306,852 premarket shares versus a 20-day average of about 25.9 million. Market cap is about $15.3M. It is gapping up 27.0%. A gap is a jump in price between one session's close and the next open.
No new company announcement on October 16 explains the move. The best-supported context is a securities class action announced October 14 by Wolf Haldenstein, covering buyers between Dec. 15, 2021 and Sept. 3, 2026. Benzinga tied an 18.85% after-hours surge to it. Netcapital also announced October 13 it regained Nasdaq minimum bid price compliance. Treat these as context, not confirmed causes. Netcapital was also in our Oct. 15 premarket recap.
The prior-day setup is strong on paper: RSI 66, ADX 47, a bullish moving-average stack, RS rating 99, technical rank 100, trend-template score 6, conviction 73/100 (grade B). Price is 21.2% below its 52-week high. Squeeze score is 45/100, with 46.9% free float, 1,651,407 shares short, 0.0 days to cover and 46% short-volume. Recent 8-Ks are tagged bearish for delisting.
After a multi-day run, the risk of a sharp reversal is high.
XLAB — Exascale Labs Holdings Inc. (+27.9%)
Exascale Labs is up 27.9% to $1.74 on 16,760,064 premarket shares, versus a 20-day average of only about 453,000. That is a huge volume surge for a name that normally trades thinly. It already rose about 49.7% on October 15.
The most specific catalyst is an $8.208 million contract with Sunon, disclosed in an 8-K around October 14–15, for 12 NVIDIA HGX B300 GPU servers (96 GPUs), supporting equipment, deployment services and 36 months of IT operations support. Sources disagree on the signing date, and it is not confirmed that this drove today's move. Coverage today cites only a generic "transformative AI partnership" with no named counterparty or terms. XLAB also featured in our Oct. 15 top movers.
Technically, the prior-day chart showed a bullish engulfing candle, RSI 30, ADX 48, a -5.9% gap and a price 73.5% below its 52-week high. Conviction is 100/100 (grade A+), technical rank 23. The squeeze score is 71/100: 100% free float, 518,598 shares short, 1.0 days to cover, 56% short-volume and an active SSR. A short squeeze happens when short sellers buy to cover and push the price higher, but it can fade quickly.
The bottom line
All four names are micro-caps with thin trading, deal- or momentum-driven spikes and dilution or listing risks. Premarket prices are lighter and can reverse at the open. Chasing extended gainers is high-risk, patterns and squeezes fail, and nothing here is a recommendation. Manage risk and do your own research. StockSetups scans the full US universe after every close and every premarket morning for setups like these.
Frequently asked questions
Why is ZTG up in premarket today?
ZTG is up 56.2% after its subsidiary ZentoAI signed a binding MOU to acquire a controlling stake in a China-based AI and big-data provider. The deal still needs due diligence, definitive agreements and board approvals.
Why is TCRT up today?
TCRT is up 31.0% premarket, tied to the completed Velaris Therapeutics acquisition and a roughly $350 million private placement announced October 13. No new October 16 event was identified.
What is a low-float short squeeze?
Float is the number of shares available to trade. When few shares trade and short sellers must buy to cover as prices rise, buying pressure can spike the price, though it often reverses.
Do premarket gains hold after the open?
Not reliably. Premarket volume is lighter, so prices swing more, and many big gainers give back part of the move once regular trading begins.
Produced with AI assistance and published under the StockSetups editorial guidelines.
Get daily signals & real-time alerts.
StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.
Start free — 14-day full access →